A CASE SERIES OF HLA-B*58:01 SPECIFIC ALLOPURINOL-INDUCED DRESS/DIHS

被引：0
|
作者：
Diaz, A.
Sani, S.
Mawhirt, S.
Banta, E.
Fonacier, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2022年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M050
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [31] Allopurinol non-covalently facilitates binding of unconventional peptides to HLA-B*58:01
    Huan, Xuelu
    Zhuo, Nicole
    Lee, Haur Yueh
    Ren, Ee Chee
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Flow cytometry test to screen for HLA-B*58:01-associated allopurinol hypersensitivity
    Mirko Scarsi
    Carla Bosio
    Silvia Coccoli
    Amilcare Barucco
    Giovanna Tavelli
    Paolo Airò
    Clinical Rheumatology, 2014, 33 : 873 - 875
  • [33] Flow cytometry test to screen for HLA-B*58:01-associated allopurinol hypersensitivity
    Scarsi, Mirko
    Bosio, Carla
    Coccoli, Silvia
    Barucco, Amilcare
    Tavelli, Giovanna
    Airo, Paolo
    CLINICAL RHEUMATOLOGY, 2014, 33 (06) : 873 - 875
  • [34] Allopurinol non-covalently facilitates binding of unconventional peptides to HLA-B*58:01
    Xuelu Huan
    Nicole Zhuo
    Haur Yueh Lee
    Ee Chee Ren
    Scientific Reports, 13
  • [35] A Rare Case of Fatal Atypical Allopurinol-induced DRESS Syndrome
    Sinclair, J.
    Chaudry, F.
    Shanmukhappa, S. Chetana
    Din, A. Tameez Ud
    Malik, M. Ahmed
    El Meedani, H.
    Duffy, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [36] The Presence of HLA-B75, DR13 Homozygosity, or DR14 Additionally Increases the Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in HLA-B*58:01 Carriers
    Shim, Ji-Su
    Yun, James
    Kim, Mi-Yeong
    Chung, Soo Jie
    Oh, Ji Hyun
    Kang, Dong-Yoon
    Jung, Jae-Woo
    Cho, Sang-Heon
    Kang, Hye-Ryun
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (04): : 1261 - 1270
  • [37] SEVERE PROTRACTED ALLOPURINOL-INDUCED DRESS/DIHS REQUIRING LONG-TERM, HIGH-DOSE IMMUNOSUPPRESSANTS
    Rosenblum, J.
    Banta, E.
    Clements, S. Nassau
    Femia, A.
    Mawhirt, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S58 - S59
  • [38] Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population
    Chong, Huey Yi
    Lim, Yi Heng
    Prawjaeng, Juthamas
    Tassaneeyakul, Wichittra
    Mohamed, Zahurin
    Chaiyakunapruk, Nathorn
    PHARMACOGENETICS AND GENOMICS, 2018, 28 (02): : 56 - 67
  • [39] HLA-B*58:01 Genotyping to Prevent Cases of DRESS and SJS']JS/TEN in East Asians Treated with Allopurinol-A Canadian Missed Opportunity
    Ponzo, Marisa Grace
    Miliszewski, Monica
    Kirchhof, Mark G.
    Keown, Paul A.
    Dutz, Jan P.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (06) : 595 - 601
  • [40] Prevalence of Human Leukocyte Antigen (HLA)-B*58:01 and Allopurinol-Induced Adverse Reactions in Filipino Patients in Hawai'i: Implications for Genotyping
    Terashima, Rika
    Medina, Alejandro Jude P.
    Del Mundo, Hans Jesper F.
    Briones, Ryan Sean S.
    Aquino, Joseph Arman B.
    Quiminiano, Ellaine M.
    Sin, Yuh Miin
    Bautista, Rhea A.
    Sonido, Charlie Y.
    Yamada, Seiji
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (02)
12345